| The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor X Chen, X Hong, G Chen, J Xue, J Huang, F Wang, J Li, L Zhang Translational Oncology 17, 101338, 2022 | 26 | 2022 |
| Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy LL Pang, JD Gan, YH Huang, J Liao, WT Zhuang, WAS Ali, SD Hong, ... BMC cancer 23 (1), 72, 2023 | 8 | 2023 |
| Investigation of the optimal platinum-based regimen in the postoperative adjuvant chemotherapy setting for early-stage resected non-small lung cancer: a Bayesian network meta … LL Pang, JD Gan, YH Huang, J Liao, Y Lv, WAS Ali, L Zhang, WF Fang BMJ open 12 (6), e057098, 2022 | 5 | 2022 |
| Determinants of survival in advanced non-small cell lung cancer patients treated with anti-PD-1/PD-L1 therapy WAS Ali, P Hui, Y Ma, Y Wu, Y Zhang, Y Chen, S Hong, Y Yang, Y Huang, ... Annals of Translational Medicine 9 (22), 2021 | 5 | 2021 |
| Reducing number of target lesions for RECIST1. 1 to predict survivals in patients with advanced non-small-cell lung cancer undergoing anti-PD1/PD-L1 monotherapy LN He, T Chen, S Fu, C Chen, Y Jiang, X Zhang, W Du, H Li, Y Wang, ... Lung Cancer 165, 10-17, 2022 | 4 | 2022 |
| Pretreatment serum lactate dehydrogenase and metastases numbers as potential determinants of anti-PD-1 therapy outcome in nasopharyngeal carcinoma WAS Ali, X Huang, Y Wu, Y Ma, H Pan, J Liao, Z Yang, S Hong, Y Yang, ... Cancer Control 30, 10732748221148912, 2023 | 2 | 2023 |
| A case report of small bowel adenocarcinoma with liver metastases: genetic profiling and clinical management WAS Ali, W Liu, Y Xiao, J Fang, Q Xu Translational Cancer Research 8 (4), 1624, 2019 | 2 | 2019 |
| 成骨与溶骨性骨转移机制差异及靶向药物进展 瓦俄， 方珏敏， 许青 现代肿瘤医学 25 (22), 3699-3703, 2017 | 1 | 2017 |
| Epidermal growth factor receptor-Mutated Non-small-cell Lung Cancer with Intracranial Progressions and Stable Extracranial Diseases Benefit from Osimertinib Regardless of T790M … J Liao, Y Huang, J Gan, L Pang, WAS Ali, Y Yang, L Chen, L Zhang, ... Cancer Control 29, 10732748221081360, 2022 | | 2022 |
